1. Home
  2. RANI
  3. RANI News

Latest Rani Therapeutics Holdings Inc. (RANI) News on February 22, 2025

RANI: Impressive Bioavailability for RT-116
RANI

Zacks Small Cap Research

4 days ago

RANI: Impressive Bioavailability for RT-116

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week
RANI

Simply Wall St.

7 days ago

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week

RANI

MT Newswires

16 days ago

Rani Therapeutics Discloses Progress in Oral Obesity Treatment; Shares Surge Premarket

Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
RANI

GlobeNewswire

17 days ago

Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC

RANI: Third Quarter Update
RANI

Zacks Small Cap Research

3 months ago

RANI: Third Quarter Update

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

3 months ago

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

Rani Therapeutics to Participate in Upcoming Investor Conferences
RANI

GlobeNewswire

3 months ago

Rani Therapeutics to Participate in Upcoming Investor Conferences

Allied Gaming & Entertainment And 2 Other US Penny Stocks To Watch
RANI

Simply Wall St.

4 months ago

Allied Gaming & Entertainment And 2 Other US Penny Stocks To Watch

RANI: New Triagonist Data in Weight Loss
RANI

Zacks Small Cap Research

4 months ago

RANI: New Triagonist Data in Weight Loss

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
RANI

GlobeNewswire

4 months ago

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

RANI

MT Newswires

4 months ago

Top Midday Decliners

RANI

MT Newswires

4 months ago

Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
RANI

GlobeNewswire

4 months ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants

Oppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy’ Stocks
RANI

TipRanks

4 months ago

Oppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy’ Stocks

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock
RANI

Simply Wall St.

4 months ago

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
RANI

GlobeNewswire

4 months ago

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

Rani Therapeutics to Participate in September Investor Conferences
RANI

GlobeNewswire

6 months ago

Rani Therapeutics to Participate in September Investor Conferences

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$12m last week
RANI

Simply Wall St.

6 months ago

Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$12m last week

RANI

Zacks Small Cap Research

6 months ago

RANI: Second Quarter Results

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

7 months ago

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

RANI

MT Newswires

7 months ago

Oppenheimer Initiates Rani Therapeutics Holdings at Outperform With $17 Price Target

Rani Therapeutics to Participate in August Investor Conferences
RANI

GlobeNewswire

7 months ago

Rani Therapeutics to Participate in August Investor Conferences

RANI

MT Newswires

7 months ago

Rani Therapeutics Prices $10 Million Registered Direct Offering

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering
RANI

GlobeNewswire

7 months ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering

RANI: GLP-2 Deal Announced
RANI

Zacks Small Cap Research

8 months ago

RANI: GLP-2 Deal Announced

RANI

MT Newswires

8 months ago

Rani Therapeutics Partners With ProGen for Oral Obesity Treatment Development; Shares Rise

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
RANI

GlobeNewswire

8 months ago

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

RANI

MT Newswires

8 months ago

Maxim Starts Coverage on Rani Therapeutics With Buy Rating, $15 Price Target

RANI

MT Newswires

9 months ago

UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating

Rani Therapeutics to Participate in May Investor Conferences
RANI

GlobeNewswire

9 months ago

Rani Therapeutics to Participate in May Investor Conferences

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
RANI

GlobeNewswire

9 months ago

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

RANI: 1Q:24 Results
RANI

Zacks Small Cap Research

9 months ago

RANI: 1Q:24 Results

Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates
RANI

GuruFocus.com

9 months ago

Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

10 months ago

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

Favourable Signals For Rani Therapeutics Holdings: Numerous Insiders Acquired Stock
RANI

Simply Wall St.

10 months ago

Favourable Signals For Rani Therapeutics Holdings: Numerous Insiders Acquired Stock

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript
RANI

Insider Monkey

a year ago

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript

RANI: 2023 Results
RANI

Zacks Small Cap Research

a year ago

RANI: 2023 Results

RANI

Thomson Reuters StreetEvents

a year ago

Q4 2023 Rani Therapeutics Holdings Inc Earnings Call

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

a year ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
RANI

GlobeNewswire

a year ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Individual investors own 40% of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shares but private companies control 47% of the company
RANI

Simply Wall St.

a year ago

Individual investors own 40% of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shares but private companies control 47% of the company

RANI: INITIATION – Realizing Oral Administration of Biologics
RANI

Zacks Small Cap Research

a year ago

RANI: INITIATION – Realizing Oral Administration of Biologics

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)
RANI

GlobeNewswire

a year ago

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)

Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics
RANI

Zacks

a year ago

Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics

Northrim BanCorp (NASDAQ:NRIM) Is Increasing Its Dividend To $0.61
RANI

Simply Wall St.

a year ago

Northrim BanCorp (NASDAQ:NRIM) Is Increasing Its Dividend To $0.61

Meridian Corporation Reports Fourth Quarter 2023 Results and Announces a Quarterly Dividend of $0.125 per Common Share
RANI

GlobeNewswire

a year ago

Meridian Corporation Reports Fourth Quarter 2023 Results and Announces a Quarterly Dividend of $0.125 per Common Share

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
RANI

GlobeNewswire

a year ago

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why
RANI

Zacks

a year ago

Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why

IX Acquisition Corp. Announces Tenth Extension of Deadline to Complete Initial Business Combination
RANI

GlobeNewswire

a year ago

IX Acquisition Corp. Announces Tenth Extension of Deadline to Complete Initial Business Combination

DocGo Provides Additional Information to Refute Misleading Short Seller "Report"
RANI

Business Wire

a year ago

DocGo Provides Additional Information to Refute Misleading Short Seller "Report"

Several Insiders Invested In Community West Bancshares Flagging Positive News
RANI

Simply Wall St.

a year ago

Several Insiders Invested In Community West Bancshares Flagging Positive News

Senseonics Holdings, Inc. Announces Business Updates
RANI

Business Wire

a year ago

Senseonics Holdings, Inc. Announces Business Updates

Next-Gen Riches: 3 Surprising Stock Picks to Boost Your $1,000 Investment
RANI

InvestorPlace

a year ago

Next-Gen Riches: 3 Surprising Stock Picks to Boost Your $1,000 Investment

Farmers & Merchants Bancorp, Inc. and F&M Bank Announces the Appointment of Ian D. Boyce to its Board of Directors
RANI

GlobeNewswire

a year ago

Farmers & Merchants Bancorp, Inc. and F&M Bank Announces the Appointment of Ian D. Boyce to its Board of Directors

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
RANI

GlobeNewswire

a year ago

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

New Strong Buy Stocks for December 13th
RANI

Zacks

a year ago

New Strong Buy Stocks for December 13th

What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock
RANI

Zacks

a year ago

What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock

Jean-Luc Butel Buys Handful Of Shares In Rani Therapeutics Holdings
RANI

Simply Wall St.

a year ago

Jean-Luc Butel Buys Handful Of Shares In Rani Therapeutics Holdings

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock
RANI

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock

Middlefield (MBCN) Stock Gains on Special Dividend Announcement
RANI

Zacks

a year ago

Middlefield (MBCN) Stock Gains on Special Dividend Announcement

Independent Director of Eastern Picks Up 9.7% More Stock
RANI

Simply Wall St.

a year ago

Independent Director of Eastern Picks Up 9.7% More Stock

RANI

GuruFocus.com

a year ago

Rani Therapeutics Holdings Inc (RANI) Reports Q3 2023 Financial Results and Corporate Developments

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
RANI

GlobeNewswire

a year ago

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Share on Social Networks: